Multiple Sclerosis and Related Disorders
AAN 2026 highlights: key trial updates across narcolepsy, movement disorders, Tourette syndrome & more!
This episode of the VJNeurology Podcast showcases key trial updates from the American Academy of Neurology Annual Meeting in Chicago,…
Date: 5th May 2026
Updates in MS research from ACTRIMS 2026: trial updates, new technologies, & more
This episode focuses on key updates in multiple sclerosis (MS) research from the 11th Annual Americas Committee for Treatment and…
Date: 3rd March 2026
CAR T-cell therapy for multiple sclerosis: insights from a Phase I trial
In this episode of the VJNeurology Podcast, Jeffrey Dunn, MD, Stanford University School of Medicine, Palo Alto, CA, shares insights…
Date: 31st October 2025
Updates to the McDonald diagnostic criteria for MS
The 2024 revision of the McDonald diagnostic criteria for multiple sclerosis (MS) was recently presented at the 40th Congress of…
Date: 28th November 2024
Evolving perspectives in MOGAD: a comprehensive research update
Myelin oligodendrocyte glycoprotein antibody-associated disorder (MOGAD) is characterized by relapsing episodes of severe immune-mediated demyelination in deep white matter tracts….
Date: 20th December 2023
The wearables revolution in neurology
Neurologists and researchers are increasingly harnessing the power of wearables to gather real-time, high-quality data about patients’ neurological conditions. From…
Date: 2nd August 2023
Biomarkers for disease progression and treatment response in MS
Biomarker development and discovery have been an important point in multiple sclerosis (MS) research for many years. Neurofilament light (NfL)…
Date: 29th March 2023
Pregnancy management in MS and NMOSD
Multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD) are chronic conditions of the central nervous system, predominantly affecting women…
Date: 25th November 2022
MS genetics and environment: new findings
With its prevalence growing globally, multiple sclerosis (MS) is the most common disabling neurologic disease to affect young adults, especially…
Date: 31st October 2022
Novel imaging biomarkers in MS diagnosis and prognostication
Magnetic resonance imaging (MRI) has emerged as a powerful, noninvasive tool for diagnosis, prognostication, and treatment monitoring in multiple sclerosis…
Date: 18th August 2022
Insight into the pathogenesis of pediatric-onset MOGAD
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is an inflammatory disorder mainly affecting the optic nerve, spinal cord, and brain. This…
Date: 11th May 2022
Optimizing clinical trial design for improved outcomes in multiple sclerosis
Measuring the efficacy of treatments for multiple sclerosis (MS) is challenging, due to the heterogeneity of disease presentation and the…
Date: 19th April 2022
